5.96

4.03% -0.25

After Hours: 6.00 0.04 +0.67%

Journey Medical Corp (DERM)

Overview News Price History Financials Discussions Forecast

Journey Medical Corp stock is traded at $5.96, with a volume of 181.84K. It is down -4.03% in the last 24 hours and up +18.25% over the past month. Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Previous Close:

$6.21

Open:

$6.26

24h Volume:

181.84K

Relative Volume:

0.73

Market Cap:

$164.11M

Revenue:

$61.86M

Net Income/Loss:

$-11.43M

P/E Ratio:

-12.37

EPS:

-0.4818

Net Cash Flow:

$-12.52M

1W Performance:

-5.85%

1M Performance:

+18.25%

6M Performance:

-20.11%

1Y Performance:

-12.61%

1-Day Range:

$5.915

$6.31

1-Week Range:

$5.915

$6.55

52-Week Range:

$4.31

$9.555

Journey Medical Corp Stock (DERM) Company Profile

Name

Journey Medical Corp

Sector

Healthcare (1108)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

480-434-6670

Address

9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE

Employee

Twitter

Next Earnings Date

2026-05-13

Latest SEC Filings

DERM's Discussions on Twitter

Compare DERM vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DERM Journey Medical Corp	5.96	170.99M	61.86M	-11.43M	-12.52M	-0.4818
TAK Takeda Pharmaceutical Co Adr	16.25	52.07B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.29	41.28B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	34.07	39.78B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	81.32	33.57B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	568.43	24.02B	3.17B	1.29B	1.01B	27.09

Journey Medical Corp Stock (DERM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-25-25	Initiated	H.C. Wainwright	Buy
Jul-30-25	Resumed	B. Riley Securities	Buy
Aug-22-24	Initiated	Rodman & Renshaw	Buy
Jun-28-24	Resumed	ROTH MKM	Buy
Dec-07-21	Initiated	B. Riley Securities	Buy

Journey Medical Corp Stock (DERM) Latest News

May 20, 2026

Best travel insurance if you have a medical condition 2026 - which.co.uk

May 20, 2026

May 19, 2026

Journey Medical CEO to join A.G.P. Virtual Healthcare Conference fireside chat on May 20, 2026 - Pluang

May 19, 2026

Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference - The Manila Times

May 19, 2026

May 17, 2026

Journey Medical Corp stock (US48113J1007): dermatology player in focus after recent financing update - AD HOC NEWS

May 17, 2026

May 16, 2026

Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT), Neurogene (NGNE) and ARS Pharmaceuticals (SPRY) - The Globe and Mail

May 16, 2026

May 15, 2026

Journey Medical Corporation (NASDAQ:DERM) Q1 2026 Earnings Call Transcript - Insider Monkey

May 15, 2026

May 14, 2026

Journey Medical Corporation Q1 2026 Earnings Call Summary - Yahoo Finance

May 14, 2026

Analyst Reiterates Buy on Journey Medical, Maintains $13 Price Target After Strong 1Q26 and Emrosi Momentum - TipRanks

May 14, 2026

Journey Medical Corp stock (US48113J1007): Q1 revenue jumps 21% to $16M - AD HOC NEWS

May 14, 2026